Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
about
Enhancers and chromatin structures: regulatory hubs in gene expression and diseases.Histone lysine demethylases in mammalian embryonic development.TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.Transcriptome analysis of miRNA-lncRNA-mRNA interactions in the malignant transformation process of gastric cancer initiation.How to stomach an epigenetic insult: the gastric cancer epigenome.Super-Enhancer-Driven Transcriptional Dependencies in Cancer.Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection.Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus.Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor.HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.Mutation hotspots at CTCF binding sites coupled to chromosomal instability in gastrointestinal cancers.Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
P2860
Q33613467-5992D47B-A8FB-4380-9DBB-E4085A7B4255Q34555991-AC3F8FEB-10D4-4779-B35A-8DA4D9E4B1CBQ38637158-BA3C5128-8FEA-42D4-8AA8-395B82302AABQ38751688-5F3EB626-9198-41EA-BD32-FAA963F7AFD3Q38775292-2A13B0DC-1800-4AA9-9AB1-2838F1671F71Q39312802-1FF7E7E5-9D4F-4925-9BE4-42D7D5B12D1DQ39441366-B048A180-5395-41F1-97DB-1D0012AA4DBDQ40043147-8F9999B3-F8BD-4401-BE96-DD78D0201408Q40085471-FA81493A-28DB-48C3-A2DD-153738769E5AQ47136892-0DA13F33-0A15-4765-958F-82B6E1E17BA1Q47379639-E0EE3BB7-F5A4-41BB-A68F-DFB3C587EFB3Q47391313-CBE7BD4C-1E1E-4B2C-AB6D-83412681C325Q47723106-A783184E-D6A0-4DBB-9DE2-4A30094603A1Q49710712-2E534B06-EA39-4E26-BA72-3368C13D193FQ52691469-25E30717-E851-4409-A388-4CE950E26CE7Q58742961-E559C904-FE9A-4C6D-B2F7-738466960130
P2860
Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenomic profiling of primar ...... super-enhancer heterogeneity.
@en
Epigenomic profiling of primar ...... super-enhancer heterogeneity.
@nl
type
label
Epigenomic profiling of primar ...... super-enhancer heterogeneity.
@en
Epigenomic profiling of primar ...... super-enhancer heterogeneity.
@nl
prefLabel
Epigenomic profiling of primar ...... super-enhancer heterogeneity.
@en
Epigenomic profiling of primar ...... super-enhancer heterogeneity.
@nl
P2093
P2860
P50
P356
P1476
Epigenomic profiling of primar ...... super-enhancer heterogeneity.
@en
P2093
Aditi Qamra
Ai Ping Lee-Lim
Astrid Irwanto
Chow Yin Wong
Deepak Babu
Hock Soo Ong
James O J Davies
James Qu Zhengzhong
P2860
P2888
P356
10.1038/NCOMMS12983
P407
P577
2016-09-28T00:00:00Z
P6179
1037259887